Page last updated: 2024-11-06

3,4-epoxy-3-methyl-1-butene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-ethenyl-2-methyloxirane: forms adducts with 2'-deoxyadenosine; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92166
MeSH IDM0271721

Synonyms (28)

Synonym
nsc-48598
nsc48598
1838-94-4
2-methyl-2-vinyloxirane, 95%
nsc 48598
3,4-epoxy-3-methyl-1-butene
2-methyl-2-vinyloxirane
ccris 5685
2-ethenyl-2-methyloxirane
unii-o364aqj1k5
o364aqj1k5 ,
oxirane, 2-ethenyl-2-methyl-
isoprene monoxide
AKOS015903306
2-methyl-2-vinyl-oxirane
3,4-epoxy-3-methyl-1-butene, (+/-)-
2-vinylpropylene oxide
isoprene epoxide
1,2-epoxy-2-methyl-3-butene
mfcd00075225
J-800023
J-640425
4,4,4-3fmet-1-(2-furyl)-1,3-butandione
J-640426
Q27285260
DTXSID701031061
EN300-130159
Z1255379160

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Subsequently, the kinetic parameters were incorporated into a physiologically-based pharmacokinetic model, and species differences regarding isoprene diepoxide levels were forecasted."( Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling.
Bogaards, JJ; Freidig, AP; van Bladeren, PJ, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.24 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]